3-Bromo-5-(1-methyl-pyrrolidin-2-yl)-pyridine

ID: ALA61772

Chembl Id: CHEMBL61772

Cas Number: 71719-09-0

PubChem CID: 11032027

Max Phase: Preclinical

Molecular Formula: C10H13BrN2

Molecular Weight: 241.13

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCCC1c1cncc(Br)c1

Standard InChI:  InChI=1S/C10H13BrN2/c1-13-4-2-3-10(13)8-5-9(11)7-12-6-8/h5-7,10H,2-4H2,1H3

Standard InChI Key:  VKHLFAFBADEABG-UHFFFAOYSA-N

Alternative Forms

Associated Targets(non-human)

Chrna3 Neuronal acetylcholine receptor (756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrnb2 Neuronal nicotinic acetylcholine receptor (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm1 Muscarinic acetylcholine receptor (3770 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna4 Neuronal acetylcholine receptor; alpha4/beta2 (3557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 241.13Molecular Weight (Monoisotopic): 240.0262AlogP: 2.61#Rotatable Bonds: 1
Polar Surface Area: 16.13Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.97CX LogP: 1.93CX LogD: 1.80
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.75Np Likeness Score: -0.55

References

1. Lee M, Dukat M, Liao L, Flammia D, Damaj MI, Martin B, Glennon RA..  (2002)  A comparison of the binding of three series of nicotinic ligands.,  12  (15): [PMID:12113825] [10.1016/s0960-894x(02)00298-6]
2. Cosford ND, Bleicher L, Herbaut A, McCallum JS, Vernier JM, Dawson H, Whitten JP, Adams P, Chavez-Noriega L, Correa LD, Crona JH, Mahaffy LS, Menzaghi F, Rao TS, Reid R, Sacaan AI, Santori E, Stauderman KA, Whelan K, Lloyd GK, McDonald IA..  (1996)  (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors.,  39  (17): [PMID:8765504] [10.1021/jm960328w]
3. Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA..  (2005)  3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands.,  15  (19): [PMID:16039854] [10.1016/j.bmcl.2005.06.053]
4. Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA..  (2005)  3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands.,  15  (19): [PMID:16039854] [10.1016/j.bmcl.2005.06.053]
5. Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA..  (2005)  3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands.,  15  (19): [PMID:16039854] [10.1016/j.bmcl.2005.06.053]

Source